STAT3 also alters metabolism in cancer cells, having been linked with elevated glucose utilization via increased expression of glycolytic enzymes as well as dysregulated lipid biosynthesis through SREBP1 and ACC1 (23, 24, 37). Here, SREBF1 is linked to cancer.